Patent · US Active

Anti-serum albumin binding variants

US9751935B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2015
Grant dateSep 5, 2017
Priority date
Expiry dateSep 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-14, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.